SAJA Pharmaceuticals

sajaonline.net

SAJA is a joint venture between the premier Saudi healthcare company, Tamer, the Saudi partner, the (SA) in SAJA and two of the leading Japanese pharmaceutical companies, Daiichi Sankyo Co., Ltd. and Astellas Pharma Inc., the Japanese partners, the (JA) in SAJA. Both companies are major players in the Japanese healthcare sector, each with an impressive portfolio of ethical medicines.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

PLURISTEM ENTERS COLLABORATION WITH PHARMACEUTICAL COMPANY INNOVARE R&D TO EXPAND PLURISTEM’S ARDS ASSOCIATED WITH COVID-19 PROGRAM TO MEXICO

Pluristem | December 30, 2020

news image

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a main regenerative medication organization building up a foundation of novel natural helpful items, reported today it has gone into a coordinated effort concurrence with Mexican drug organization Innovare R&D to extend its continuous clinical program of PLX cells in the treatment of Acute Respiratory Distress Syndrome (ARDS) related with COVID-19 in Mexico. The Phase II investigation in Mexico is dependent upon the endorsement of neighb...

Read More

Pharma Tech

KSP SPECIALTY PHARMACY NOW OFFERS ACCESS TO NON-ONCOLOGY DRUGS AND LAUNCHES NEW WEBSITE FEATURING PHARMACY PATIENT PORTAL

Karmanos Cancer Institute | October 05, 2021

news image

The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) are pleased to announce the launch of new services and a new website: www.ksppharmacy.org. The new site features provider resources and information for payers and pharmaceutical companies. Most notably, the site includes an online portal where patients can refill their prescriptions. This tool also allows patients to see their list of medications, get reminders and interact with their pharmacist. A portal for patient educ...

Read More

Pharmacy Market

XERIS BIOPHARMA ANNOUNCES RESEARCH EVALUATION COLLABORATION AND OPTION AGREEMENT WITH REGENERON FOR XERIJECT™

businesswire | April 03, 2023

news image

Xeris Biopharma Holdings, Inc. a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas, today announced that it has entered into a platform research evaluation collaboration and option agreement with Regeneron Pharmaceuticals, Inc. Under the terms of the agreement, Xeris will use its proprietary drug-formulation platform, XeriJect™, to develop ultra-highly concentrated, ...

Read More

Pharma Tech

ADVAXIS AND AYALA PHARMACEUTICALS ENTER INTO MERGER AGREEMENT

Advaxis and Ayala Pharmaceuticals | October 20, 2022

news image

Ayala Pharmaceuticals, Inc. a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers and Advaxis, Inc. a biotechnology company devoted to the discovery, development and commercialization of immunotherapies based on a technology which uses engineered Listeria monocytogenes, today announced that they have entered into a definitive merger agreement. The merger would result in a combined com...

Read More
news image

Research

PLURISTEM ENTERS COLLABORATION WITH PHARMACEUTICAL COMPANY INNOVARE R&D TO EXPAND PLURISTEM’S ARDS ASSOCIATED WITH COVID-19 PROGRAM TO MEXICO

Pluristem | December 30, 2020

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a main regenerative medication organization building up a foundation of novel natural helpful items, reported today it has gone into a coordinated effort concurrence with Mexican drug organization Innovare R&D to extend its continuous clinical program of PLX cells in the treatment of Acute Respiratory Distress Syndrome (ARDS) related with COVID-19 in Mexico. The Phase II investigation in Mexico is dependent upon the endorsement of neighb...

Read More
news image

Pharma Tech

KSP SPECIALTY PHARMACY NOW OFFERS ACCESS TO NON-ONCOLOGY DRUGS AND LAUNCHES NEW WEBSITE FEATURING PHARMACY PATIENT PORTAL

Karmanos Cancer Institute | October 05, 2021

The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) are pleased to announce the launch of new services and a new website: www.ksppharmacy.org. The new site features provider resources and information for payers and pharmaceutical companies. Most notably, the site includes an online portal where patients can refill their prescriptions. This tool also allows patients to see their list of medications, get reminders and interact with their pharmacist. A portal for patient educ...

Read More
news image

Pharmacy Market

XERIS BIOPHARMA ANNOUNCES RESEARCH EVALUATION COLLABORATION AND OPTION AGREEMENT WITH REGENERON FOR XERIJECT™

businesswire | April 03, 2023

Xeris Biopharma Holdings, Inc. a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas, today announced that it has entered into a platform research evaluation collaboration and option agreement with Regeneron Pharmaceuticals, Inc. Under the terms of the agreement, Xeris will use its proprietary drug-formulation platform, XeriJect™, to develop ultra-highly concentrated, ...

Read More
news image

Pharma Tech

ADVAXIS AND AYALA PHARMACEUTICALS ENTER INTO MERGER AGREEMENT

Advaxis and Ayala Pharmaceuticals | October 20, 2022

Ayala Pharmaceuticals, Inc. a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers and Advaxis, Inc. a biotechnology company devoted to the discovery, development and commercialization of immunotherapies based on a technology which uses engineered Listeria monocytogenes, today announced that they have entered into a definitive merger agreement. The merger would result in a combined com...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us